Allergan Inc. should put any acquisition it might strike in the coming weeks to a shareholder vote, proxy advisory firm Institutional Shareholder Services said in a report critical of the company's handling of a hostile bid.
from WSJ.com: US Business http://ift.tt/1vxpDax
via IFTTT
from WSJ.com: US Business http://ift.tt/1vxpDax
via IFTTT
No comments:
Post a Comment